ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 155

Absence of Clinical and Ultrasound Activity of Hand and Foot: Is That Possible?: Experience in an Argentinian Rheumatoid Arthritis Cohort 

María Victoria Martire1, Gloria Crespo2, Diego Puente Trigo2, Vanesa Duarte2, Maritza Manzano2, Leandro Carlevaris Sr.2, Anastasia Secco2, Lida Santiago2, Marta Mamani2 and Lucila Marino Claverie2, 1Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 2Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: remission, rheumatoid arthritis (RA) and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Imaging of Rheumatic Diseases Poster I: Ultrasound, Optical Imaging and Capillaroscopy

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Currently, one of the main goals of rheumatoid arthritis (RA) treatment is to attain remission. Stricter criteria as CDAI, SDAI ACR/ EULAR Boolean have been proposed. Patients with RA, who achieve clinical remission may have residual joint inflammation, which can be detected by ultrasonography (US). However the degree of agreement that stricter criteria present with US findings in patients in remission is not well known, especially on feet assessment. The aim of this study was to assess subclinical synovitis by US and to evaluate the degree of agreement between the remission status as measured by different strict criteria and the absence of activity using US of hands and toes.

Methods: US examination was performed consecutively on 100 patients with RA fullfiling 2010 ACR EULAR criteria that were in clinical remission (DAS 28-ESR<2.6) for at least 6 months. We evaluated if strict criteria were met (CDAI, SDAI, Boolean, Boolean without VAS general health patient). A rheumatologist specialized in musculoskeletal US, blinded to clinical activity, performed a systematic evaluation on grayscale and power Doppler technique with multifrequency linear transducer (10-18MHz) in longitudinal and transverse sections. The radiocarpal joint, second and third metacarpophalangeal, second and third proximal interphalangeal in both hands and second to fifth metatarsophalangeal joints were assessed bilaterally. Absence of activity was defined as absence of exudative synovitis grade II and III, and power Doppler grade II and III in all the evaluated joints.

Results: 100 US were performed in 1.800 joints of 100 patients. 80% were women (n = 80) and the mean age was 52.7 standar desviation (SD) 12. There were no differences in age, sex, disease duration, treatment, or rheumatois factor andanti-citrullinated protein antibodies positivity between patients with ultrasound activity and without it. The mean DAS28-ESR was 2 SD 0,47, 22% were receiving biologic therapy, the mean disease duration was 8.5 IQR 5-14 years and the mean duration of remission was 11.3 months SD 6. Table 1 shows the remission status in the evaluated patients. Table 2 shows the degree of agreement among different criteria and the absence of activity assessed by ultrasound of hands and feet.

 Table 1

 

Ultrasound with  activity in hands

n  (%)

Ultrasound with  activity in foot

n (%)

Ultrasound without  activity in hands

n  (%)

Ultrasound without activity in foot

n  (%)

Remission by Boolean n:45

26 (58)

8 (18)

19 (42)

37 (82)

Remission by Boolean without VAS n:71

30 (42)

 

18 (25)

41 (58)

53 (75)

Remission by SDAI n:70

34 (48)

19 (27)

36 (52)

51 (73)

Remission by CDAI n: 62

51 (82)

17 (27)

11 (18)

45 (72)

 Table 2

Remission criteria

Agreement

CI 95

Boolean ACR/EULAR

k- 0,1

-0,3-0,09

Boolean without VAS

k  0,4

O,22-0,53

SDAI

k 0,27

0,11-0,42

CDAI

k -0,07

-0,21-0,07

Conclusion: Residual joint inflammation was detected by US in patients in clinical remission on both hands and feet. There was no agreement between the remission status measured by the strict criteria and the absence of activity assessed by US of hands and feet in this study population. Only acceptable agreement was found in hands, with the Boolean criteria that excludes VAS.


Disclosure: M. V. Martire, None; G. Crespo, None; D. Puente Trigo, None; V. Duarte, None; M. Manzano, None; L. Carlevaris Sr., None; A. Secco, None; L. Santiago, None; M. Mamani, None; L. Marino Claverie, None.

To cite this abstract in AMA style:

Martire MV, Crespo G, Puente Trigo D, Duarte V, Manzano M, Carlevaris L Sr., Secco A, Santiago L, Mamani M, Marino Claverie L. Absence of Clinical and Ultrasound Activity of Hand and Foot: Is That Possible?: Experience in an Argentinian Rheumatoid Arthritis Cohort  [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/absence-of-clinical-and-ultrasound-activity-of-hand-and-foot-is-that-possible-experience-in-an-argentinian-rheumatoid-arthritis-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/absence-of-clinical-and-ultrasound-activity-of-hand-and-foot-is-that-possible-experience-in-an-argentinian-rheumatoid-arthritis-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology